BECKY VINCENTI: Open Payments
NPI 1376315978 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 30 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $423 · 2025 $648
Food & beverage: $638Education: $10
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 13 | $178 |
| Hologic Sales and Service, LLC | 3 | $141 |
| Astellas Pharma US Inc | 4 | $86 |
| Sumitomo Pharma America, Inc. | 3 | $72 |
| Organon LLC | 2 | $42 |
| CooperSurgical, Inc. | 1 | $34 |
| Davol Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Smith+Nephew, Inc. | 1 | $18 |
Products named: ZURZUVAE, ACESSA PROVU SYSTEM, Veozah, MYFEMBREE, NEXPLANON, Paragard T 380A, ARISTA, LO LOESTRIN FE.
Industry payments across AZ — which companies pay providers there.
